DJIA 17,708.79 30.56 0.17%
NASDAQ 4,882.75 19.38 0.40%
S&P 500 2,059.06 2.91 0.14%
market minute promo

Johnson & Johnson (NYSE: JNJ)

company name or ticker
Company Photos
(Click to zoom)

Bristol-Myers Squibb Co. Is Back in the Hepatitis C Race

Bristol-Myers Squibb is pursuing FDA approval that would allow its daclatasvir to be used alongside Sovaldi in genotype 3 patients.

10 Dividend Growth Stocks For March 2015

Abbott Laboratories: Dividend Stock Analysis

Here Is How Much Lawsuits Cost J&J Every Year

As Biogen Prepares to Reveal Alzheimer's Data, Expectations Are High

Interesting May Stock Options for Johnson & Johnson

10 Great Stocks to Invest in for Your Retirement

Not all stocks make great retirement investments, but these 10 work very well.

Dividend Champions: 15 Increases Expected By The End Of May

Johnson & Johnson Unfazed By $25 Million Fine

Nasdaq Dividend Achievers: Southern Company

See More Articles...